139 related articles for article (PubMed ID: 38385290)
1.
Pennisi G; Maurotti S; Ciociola E; Jamialahmadi O; Bertolazzi G; Mirarchi A; Bergh PO; Scionti F; Mancina RM; Spagnuolo R; Tripodo C; Boren J; Petta S; Romeo S
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1086-1097. PubMed ID: 38385290
[TBL] [Abstract][Full Text] [Related]
2. Physiological roles and regulation of hepatic angiopoietin-like protein 3 in Japanese Black cattle (Bos taurus) during the fattening period.
Shikida R; Kim M; Futohashi M; Nishihara K; Lee H; Suzuki Y; Baek Y; Masaki T; Ikuta K; Iwamoto E; Uemoto Y; Haga S; Terada F; Roh S
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37317898
[TBL] [Abstract][Full Text] [Related]
3. ANGPTL3 negatively regulates IL-1β-induced NF-κB activation by inhibiting the IL1R1-associated signaling complex assembly.
Zhang Y; Zhang ZT; Wan SY; Yang J; Wei YJ; Chen HJ; Zhou WZ; Song QY; Niu SX; Zheng L; Huang K
J Mol Cell Biol; 2024 Jan; 15(8):. PubMed ID: 37634084
[TBL] [Abstract][Full Text] [Related]
4. ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
D'Erasmo L; Di Martino M; Neufeld T; Fraum TJ; Kang CJ; Burks KH; Di Costanzo A; Minicocci I; Bini S; Maranghi M; Pigna G; Labbadia G; Zheng J; Fierro D; Montali A; Ceci F; Catalano C; Davidson NO; Lucisano G; Nicolucci A; Arca M; Stitziel NO
Circulation; 2023 Nov; 148(19):1479-1489. PubMed ID: 37712257
[TBL] [Abstract][Full Text] [Related]
5. Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation.
Tikka A; Soronen J; Laurila PP; Metso J; Ehnholm C; Jauhiainen M
Biosci Rep; 2014 Dec; 34(6):e00160. PubMed ID: 25495645
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
Graham MJ; Lee RG; Brandt TA; Tai LJ; Fu W; Peralta R; Yu R; Hurh E; Paz E; McEvoy BW; Baker BF; Pham NC; Digenio A; Hughes SG; Geary RS; Witztum JL; Crooke RM; Tsimikas S
N Engl J Med; 2017 Jul; 377(3):222-232. PubMed ID: 28538111
[TBL] [Abstract][Full Text] [Related]
7. Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia.
Gaudet D; Karwatowska-Prokopczuk E; Baum SJ; Hurh E; Kingsbury J; Bartlett VJ; Figueroa AL; Piscitelli P; Singleton W; Witztum JL; Geary RS; Tsimikas S; O'Dea LSL;
Eur Heart J; 2020 Oct; 41(40):3936-3945. PubMed ID: 32860031
[TBL] [Abstract][Full Text] [Related]
8. The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models.
Lin CY; Chen PY; Hsu HJ; Gao WY; Wu MJ; Yen JH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293338
[TBL] [Abstract][Full Text] [Related]
9. ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins.
Ruhanen H; Haridas PAN; Minicocci I; Taskinen JH; Palmas F; di Costanzo A; D'Erasmo L; Metso J; Partanen J; Dalli J; Zhou Y; Arca M; Jauhiainen M; Käkelä R; Olkkonen VM
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jul; 1865(7):158679. PubMed ID: 32151767
[TBL] [Abstract][Full Text] [Related]
10. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
Robciuc MR; Maranghi M; Lahikainen A; Rader D; Bensadoun A; Öörni K; Metso J; Minicocci I; Ciociola E; Ceci F; Montali A; Arca M; Ehnholm C; Jauhiainen M
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1706-13. PubMed ID: 23661675
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.
Akoumianakis I; Zvintzou E; Kypreos K; Filippatos TD
Curr Atheroscler Rep; 2021 Mar; 23(5):20. PubMed ID: 33694000
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like 3 in lipoprotein metabolism.
Kersten S
Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
[TBL] [Abstract][Full Text] [Related]
13. A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease.
Hu X; Fan J; Ma Q; Han L; Cao Z; Xu C; Luan J; Jing G; Nan Y; Wu T; Zhang Y; Wang H; Zhang Y; Ju D
J Nanobiotechnology; 2022 May; 20(1):237. PubMed ID: 35590366
[TBL] [Abstract][Full Text] [Related]
14. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-Like 3: From Discovery to Therapeutic Gene Editing.
Wang X; Musunuru K
JACC Basic Transl Sci; 2019 Oct; 4(6):755-762. PubMed ID: 31709322
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.
Minicocci I; Tikka A; Poggiogalle E; Metso J; Montali A; Ceci F; Labbadia G; Fontana M; Di Costanzo A; Maranghi M; Rosano A; Ehnholm C; Donini LM; Jauhiainen M; Arca M
J Lipid Res; 2016 Jun; 57(6):1097-107. PubMed ID: 27040449
[TBL] [Abstract][Full Text] [Related]
17. Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.
Bergmark BA; Marston NA; Bramson CR; Curto M; Ramos V; Jevne A; Kuder JF; Park JG; Murphy SA; Verma S; Wojakowski W; Terra SG; Sabatine MS; Wiviott SD;
Circulation; 2022 May; 145(18):1377-1386. PubMed ID: 35369705
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.
Chen PY; Gao WY; Liou JW; Lin CY; Wu MJ; Yen JH
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298929
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-Like 3 Protein Inhibition: A New Frontier in Lipid-Lowering Treatment.
Lang W; Frishman WH
Cardiol Rev; 2019; 27(4):211-217. PubMed ID: 31008773
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.
Mohamed F; Mansfield BS; Raal FJ
Curr Atheroscler Rep; 2022 Dec; 24(12):959-967. PubMed ID: 36367663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
